D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Liberty Media Series C
FWONK
|
+$422M |
| 2 |
Alibaba
BABA
|
+$360M |
| 3 |
HP
HPQ
|
+$296M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Gilead Sciences
GILD
|
+$242M |
Top Sells
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
AbbVie
ABBV
|
+$324M |
| 3 |
Liberty Media Series A
FWONA
|
+$314M |
| 4 |
GE Aerospace
GE
|
+$229M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| 1 | Technology | 13.85% |
| 2 | Consumer Discretionary | 12.91% |
| 3 | Energy | 12.08% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVHI
2201
DELISTED
A V Homes, Inc.
AVHI
| $174K | ﹤0.01% |
11,865
+1,074
| +10% | +$15.8K |
|
|
ARR
2202
Armour Residential REIT
ARR
$1.74B
| $172K | ﹤0.01% |
1,114
-8,218
| -88% | -$1.27M |
|
|
RDEN
2203
DELISTED
ELIZABETH ARDEN INC
RDEN
| $168K | ﹤0.01% |
+10,060
| New | +$168K |
|
|
SAPE
2204
DELISTED
SAPIENT CORP
SAPE
| $168K | ﹤0.01% |
11,995
-36,352
| -75% | -$509K |
|
2205
Xencor
XNCR
$596M
| $166K | ﹤0.01% |
+17,813
| New | +$166K |
|
2206
Diana Shipping
DSX
$214M
| $157K | ﹤0.01% |
+25,174
| New | +$157K |
|
2207
Ultralife
ULBI
$112M
| $157K | ﹤0.01% |
48,498
| – | – |
|
|
AF
2208
DELISTED
Astoria Financial Corporation
AF
| $156K | ﹤0.01% |
+12,627
| New | +$156K |
|
|
ACAS
2209
DELISTED
American Capital Ltd
ACAS
| $156K | ﹤0.01% |
10,997
-21,603
| -66% | -$306K |
|
2210
First Busey Corp
BUSE
$2.19B
| $154K | ﹤0.01% |
9,242
+881
| +11% | +$14.7K |
|
2211
Viavi Solutions
VIAV
$2.66B
| $154K | ﹤0.01% |
21,096
-23,909
| -53% | -$175K |
|
|
FRED
2212
DELISTED
Fred's Inc
FRED
| $154K | ﹤0.01% |
11,033
-2,350
| -18% | -$32.8K |
|
2213
Nordic American Tanker
NAT
$675M
| $153K | ﹤0.01% |
19,354
-69,061
| -78% | -$546K |
|
2214
Opko Health
OPK
$1.12B
| $150K | ﹤0.01% |
17,579
-74,832
| -81% | -$639K |
|
|
REE
2215
DELISTED
RARE ELEMENT RES LTD
REE
| $150K | ﹤0.01% |
231,946
-127,637
| -35% | -$82.5K |
|
|
RNDY
2216
DELISTED
ROUNDYS INC COM STK
RNDY
| $150K | ﹤0.01% |
50,189
-114,570
| -70% | -$342K |
|
|
AAV
2217
DELISTED
Advantage Oil & Gas Ltd
AAV
| $149K | ﹤0.01% |
29,417
-46,900
| -61% | -$238K |
|
|
IMUC
2218
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $148K | ﹤0.01% |
4,156
+349
| +9% | +$12.4K |
|
2219
Alto Ingredients
ALTO
$89M
| $146K | ﹤0.01% |
+10,469
| New | +$146K |
|
2220
Cerus
CERS
$226M
| $143K | ﹤0.01% |
+35,687
| New | +$143K |
|
|
RSYS
2221
DELISTED
Radisys Corp
RSYS
| $141K | ﹤0.01% |
52,994
| – | – |
|
2222
Banco Santander
SAN
$148B
| $139K | ﹤0.01% |
16,086
| – | – |
|
|
ENG
2223
DELISTED
ENGlobal Corp
ENG
| $138K | ﹤0.01% |
8,048
| – | – |
|
2224
Oramed Pharmaceuticals
ORMP
$95.5M
| $137K | ﹤0.01% |
17,003
-5,041
| -23% | -$40.6K |
|
|
ANV
2225
DELISTED
ALLIED NEVADA GOLD CORP
ANV
| $134K | ﹤0.01% |
40,525
+598
| +1% | +$1.98K |
|